Investigating how immune responses and antibiotic use affect sepsis in children
Official title: PediatRic sEpsiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) study
Funded at Children's Hosp of Philadelphia · NIH-11094091 · Data updated 2026-11-12
This study is looking at how kids with sepsis and multi-organ dysfunction respond to antibiotics, so we can find the best way to give them the right medicine based on their unique immune systems and gut bacteria, helping them get better faster.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | June 19, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $669,906 |
| NIH project number | 5R01HD110921-03 |
| Project ID | NIH-11094091 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children aged 0-11 years who are diagnosed with sepsis and experiencing multi-organ dysfunction.
✕Less likely to help
Patients who are not diagnosed with sepsis or are older than 11 years may not benefit from this research.
What this research studies
This research focuses on understanding the relationship between immune responses, antibiotic pharmacokinetics, and the microbiome in children suffering from sepsis and multi-organ dysfunction syndrome (MODS). By examining how these factors interact, the study aims to optimize antibiotic dosing and improve treatment outcomes for pediatric patients. The research will involve analyzing blood samples and other clinical data to identify variations in antibiotic effectiveness based on individual immune responses and microbiome composition. This approach seeks to ensure that children receive the most effective antibiotic treatment tailored to their specific needs.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized antibiotic treatments for children with sepsis, potentially reducing morbidity and mortality.
How similar studies have gone: Previous research has shown promising results in understanding the immune response and antibiotic effectiveness in pediatric populations, indicating that this approach has potential for success.
Where this research is happening
-
Children's Hosp of Philadelphia
Philadelphia, United States Active
Researchers
- Principal investigator: Downes, Kevin James — Children's Hosp of Philadelphia
- Study coordinator: Downes, Kevin James
Related research
Other NIH-funded projects on the same topics.
-
Role of blood flow mechanics and transfusion in sepsis-related tiny-cl vessel clots
A patient-focused look at how red blood cell flow and transfusions might influence tiny blood vessel clots and organ problems in sepsis.
-
STeroids and enhanced Antibiotics for sepsis in Africa with HIV/TB (STARS)
This grant tests whether adding steroids and stronger antibiotics helps adults with severe sepsis tied to HIV/TB in areas with high TB rates.
-
Steroids and better antibiotics for sepsis in people with AIDS in Africa
This study tests whether adding hydrocortisone and stronger antibiotics can improve survival for adults with sepsis who also have AIDS or advanced immune suppression in regions with high TB.
-
Coordinating ARDS, Pneumonia, and Sepsis research to improve care
A national coordinating center helps researchers studying ARDS and related infections work together more efficiently to learn what helps patients recover.
-
Role of MMP3 in heart dysfunction during sepsis
This research tests whether blocking MMP3 can protect the heart and improve survival during sepsis in adults.
-
Sepsis patient care guided by Ugandan-wide immune profiling
A large NIH-funded study will map how the immune system behaves during sepsis in people in Uganda to improve personalized care for sepsis patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.